Shelby Compton's practice is focused on M&A, corporate governance, and general corporate and securities matters. She advises public and private companies on domestic and cross-border mergers, acquisitions, and divestitures of all sizes.
Shelby represents clients from a broad range of industries, including biopharmaceuticals, medical devices, pharmaceuticals, technology, energy, telecommunications, and retail. Representative clients include Abbott Laboratories, Astellas Pharma US, the Internet Corporation for Assigned Names and Numbers (ICANN), Sumitomo Corporation, and Western Digital.
- University of Notre Dame (J.D. magna cum laude 2018; Symposium Editor, The Notre Dame Law Review); Northern Arizona University (B.S. in Hospitality summa cum laude 2015)